Abstract
Rationale:: The parasympathetic reduction in heart rate involves the sequential activation of m2 muscarinic cholinergic receptors (m 2 Rs), pertussis toxin–sensitive (Gi/o) heterotrimeric G proteins, and the atrial potassium channel I KACh . Molecular mechanisms regulating this critical signal transduction pathway are not fully understood. Objective:: To determine whether the G protein signaling regulator Rgs6/Gβ5 modulates m 2 R- I KACh signaling and cardiac physiology. Methods and Results:: Cardiac expression of Rgs6, and its interaction with Gβ5, was demonstrated by immunoblotting and immunoprecipitation. Rgs6 −/− mice were generated by gene targeting, and the cardiac effects of Rgs6 ablation were analyzed by whole-cell recordings in isolated cardiomyocytes and ECG telemetry. Loss of Rgs6 yielded profound delays in m 2 R- I KACh deactivation kinetics in both neonatal atrial myocytes and adult sinoatrial nodal cells. Rgs6 −/− mice exhibited mild resting bradycardia and altered heart rate responses to pharmacological manipulations that were consistent with enhanced m 2 R- I KACh signaling. Conclusions:: The cardiac Rgs6/Gβ5 complex modulates the timing of parasympathetic influence on atrial myocytes and heart rate in mice.

This publication has 14 references indexed in Scilit: